These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 16955057)

  • 41. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure.
    Omland T
    Crit Care Med; 2008 Jan; 36(1 Suppl):S17-27. PubMed ID: 18158473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of the pulmonary artery catheter in diagnosis and management of heart failure.
    Kahwash R; Leier CV; Miller L
    Heart Fail Clin; 2009 Apr; 5(2):241-8. PubMed ID: 19249692
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma NT-proBNP: a new biomarker for diagnosis and monitoring of congestive heart failure (CHF).
    Bayes-Genis A
    Timely Top Med Cardiovasc Dis; 2006 Apr; 10():E10. PubMed ID: 17066132
    [No Abstract]   [Full Text] [Related]  

  • 44. Natriuretic peptides in heart failure: their role in daily practice.
    Loboz-Grudzień K; Jaroch J
    Cardiol J; 2009; 16(1):1-3. PubMed ID: 19130409
    [No Abstract]   [Full Text] [Related]  

  • 45. Interleukin-6 and tumor necrosis factor-alpha as biochemical markers of heart failure: a head-to-head clinical comparison with B-type natriuretic peptide.
    Boffa GM; Zaninotto M; Sartor R; Mion M; Berton A; Pasqualetto C; Razzolini R; Plebani M
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):758-64. PubMed ID: 19553828
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A critical link between heart failure self-care and intrathoracic impedance.
    Rathman LD; Lee CS; Sarkar S; Small RS
    J Cardiovasc Nurs; 2011; 26(4):E20-6. PubMed ID: 21076309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integrating device-based monitoring into clinical practice: insights from a large heart failure clinic.
    Small RS
    Am J Cardiol; 2007 May; 99(10A):17G-22G. PubMed ID: 17512418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.
    Maisel AS; Peacock WF; McMullin N; Jessie R; Fonarow GC; Wynne J; Mills RM
    J Am Coll Cardiol; 2008 Aug; 52(7):534-40. PubMed ID: 18687247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The clinical value of rapid assay for plasma B-type natriuretic peptide in differentiating congestive heart failure from pulmonary causes of dyspnoea.
    Zhao SQ; Hu YM; Li Q; Liu XR; Wang M; Zhang WY; Wu T; Nie XL; Zhao N; Wang LR
    Int J Clin Pract; 2008 Feb; 62(2):214-20. PubMed ID: 18081799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. B-type natriuretic peptide in the management of patients with congestive heart failure.
    Menon PV; Glancy DL
    J La State Med Soc; 2004; 156(2):78-82. PubMed ID: 15106865
    [No Abstract]   [Full Text] [Related]  

  • 51. The use of B-type natriuretic peptide to diagnose congestive heart failure.
    Gray JR
    Clin Lab Sci; 2006; 19(4):214-7. PubMed ID: 17181125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Are hemodynamic parameters predictors of mortality?
    Haas GJ; Leier CV
    Heart Fail Clin; 2009 Apr; 5(2):229-40. PubMed ID: 19249691
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hypertensive heart disease associated with heart failure].
    Ishikawa J; Shimada K; Kario K
    Nihon Rinsho; 2007 May; 65 Suppl 5():531-8. PubMed ID: 17571430
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of growth hormone treatment on B-type natriuretic peptide as a marker of heart failure in adults with growth hormone deficiency.
    Wallaschofski H; Saller B; Spilcke-Liss E; Lerch MM; Lohmann T; Eigenthaler M
    Horm Metab Res; 2006 Oct; 38(10):656-61. PubMed ID: 17075774
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Natriuretic peptides: putting the evidence into practice.
    Andrade A; Sharar H
    Can J Cardiovasc Nurs; 2008; 18(4):34-9. PubMed ID: 19093420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide.
    May HT; Horne BD; Levy WC; Kfoury AG; Rasmusson KD; Linker DT; Mozaffarian D; Anderson JL; Renlund DG
    Am J Cardiol; 2007 Aug; 100(4):697-700. PubMed ID: 17697831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exercise training in patients with stable chronic heart failure: effects on thoracic impedance cardiography and B-type natriuretic peptide.
    Butterfield JA; Faddy SC; Davidson P; Ridge B
    J Cardiopulm Rehabil Prev; 2008; 28(1):33-7. PubMed ID: 18277828
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of acute decompensated heart failure.
    Varughese S
    Crit Care Nurs Q; 2007; 30(2):94-103. PubMed ID: 17356351
    [TBL] [Abstract][Full Text] [Related]  

  • 60. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure.
    Tang WH; Francis GS; Morrow DA; Newby LK; Cannon CP; Jesse RL; Storrow AB; Christenson RH;
    Clin Biochem; 2008 Mar; 41(4-5):210-21. PubMed ID: 18048022
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.